'Wild speculations': BeiGene hits back at short seller's accusations of 60% sales inflation
admin 9th September 2019 Uncategorised 0BeiGene leapfrogged onto the commercial stage thanks to its acquisition of Celgene’s Chinese operations. But now, those very assets have attracted some serious allegations as a New York investment shop accuses the firm of inflating its sales by 60%.
More: 'Wild speculations': BeiGene hits back at short seller's accusations of 60% sales inflation
Source: fierce